Muti-Omics Integrated Analysis Reveals Altered metabolism in Sarcopenia.
Ontology highlight
ABSTRACT:
ORGANISM(S): Homo Sapiens
SUBMITTER: 
Tao Li
PROVIDER: PXD055032 | iProX | Wed Aug 21 00:00:00 GMT+01:00 2024
REPOSITORIES: iProX
Similar Datasets
Project description:To investigate the metabolic dysfunction in the process of sarcopenia, we collected the skeletal muscles from the participants of healthy aged, pre-sarcopenia and sarcopenia. We then performed gene expression profiling analysis using data obtained from RNA-seq of skeletal muscle tissue from healthy aged, pre-sarccopenia and sarcopenia.
2024-02-22 | GSE226151 | GEO
Project description:Muti-Omics Integrated Analysis Reveals Altered metabolism in Sarcopenia.
| PRJNA939093 | ENA
Project description:Molecular mechanisms underlying sarcopenia, the age-related loss of skeletal muscle mass and function, remain unclear. To identify molecular changes that correlated best with sarcopenia and might contribute to its pathogenesis, we determined global gene expression profiles in muscles of rats aged 6, 12, 18, 21, 24, and 27 months. These rats exhibit sarcopenia beginning at 21 months. Correlation of the gene expression versus muscle mass or age changes, and functional annotation analysis identified gene signatures of sarcopenia distinct from gene signatures of aging. Specifically, mitochondrial energy metabolism (e.g., tricarboxylic acid cycle and oxidative phosphorylation) pathway genes were the most downregulated and most significantly correlated with sarcopenia. Also, perturbed were genes/pathways associated with neuromuscular junction patency (providing molecular evidence of sarcopenia-related functional denervation and neuromuscular junction remodeling), protein degradation, and inflammation. Proteomic analysis of samples at 6, 18, and 27 months confirmed the depletion of mitochondrial energy metabolism proteins and neuromuscular junction proteins. Together, these findings suggest that therapeutic approaches that simultaneously stimulate mitochondrogenesis and reduce muscle proteolysis and inflammation have potential for treating sarcopenia.
2018-08-21 | GSE118825 | GEO
Project description:Sarcopenia, the age-related loss of skeletal muscle mass and strength, is a significant cause of morbidity in the elderly and is a major burden on health care systems. Unfortunately, the underlying molecular mechanisms in sarcopenia remain poorly understood. Herein, we utilized top-down proteomics to elucidate sarcopenia-related changes in the fast- and slow-twitch skeletal muscles of aging rats with a focus on the sarcomeric proteome, which includes both myofilament and Z-disc proteins--the proteins that constitute the contractile apparatuses.
2017-06-12 | MSV000081157 | MassIVE
Project description:To gain new insights into molecular changes in skeletal muscle aging and disease with a special focus on differential alternative splicing and senescence, we performed RNA-seq on rat gastrocnemius muscles of animals aged 6, 12, 18, 21, 24 and 27 months, using a rat sarcopenia model we had previously established.
2021-06-26 | E-MTAB-10583 | biostudies-arrayexpress
Project description:Glial cell line-derived neurotrophic factor family receptor α-like (GFRAL) is the exclusive receptor for growth differentiation factor 15 (GDF15) and plays distinct roles in various diseases. However, its impact on sarcopenia remains poorly understood. This study, comprising participants of White British and Chinese descent, demonstrated that elevated serum levels of GDF15 and its receptor GFRAL are associated with an increased risk of sarcopenia, particularly among individuals with low physical performance. While GDF15 exerts effects across the whole population, GFRAL appears to be more detrimental in women. Complementary single-cell RNA sequencing and immunohistochemical analyses in animal models further support the involvement of the GDF15–GFRAL axis in mediating skeletal muscle damage. These findings highlight the clinical and preventive relevance of the GDF15–GFRAL axis and underscore the need for future mechanistic studies to elucidate its role in sarcopenia.
2026-03-11 | GSE316316 | GEO
Project description:Skeletal muscle allows voluntary movement and plays a key role in regulating metabolism and homeostasis in the organism. Adult muscle stem cells, MuSCs, are responsible for muscle growth and regeneration. Skeletal muscle suffers from sarcopenia (muscle mass and function loss) during the aging process. Burgeoning evidence suggests that cellular senescence drives MuSC dysfunction in muscle aging. Activation of senescence-associated secretory phenotype (SASP) factors, which is one of the hallmarks of senescence, may be a driving mechanism of sarcopenia but no study so far has clearly defined cellular senescence atlas and SASP components in aging human muscles. Here in this study we propose to profile aging and senescence atlases in aging muscles using the state-of-art multiomics approaches. Our pilot results demonstrate the prevalence of cellular senescence and the dynamics/heterogeneity of SASPs in aging human muscle. Furthermore, regulators governing senescence state and SASP induction were defined. Moreover, we demonstrated the potential of senotherapeutic targeting for sarcopenia treatment. In the project we propose (1) To complete single cell multiomics mapping of aging muscle atlas. (2) To further elucidate cellular senescence in aging muscle. (3) To investigate JUNB regulation of MuSC SASP induction in aging muscle. (4) To test the potential use of senotherapeutics on aging muscle. Once completed, findings from this study will uncover novel knowledge of how MuSC senescence is involved in niche alteration and muscle aging through SASPs and demonstrate the possibility of developing senotherapeutics for treating sarcopenia.
2025-05-09 | GSE268407 | GEO
Project description:Sarcopenia, the age-associated decline in skeletal muscle mass and function, remains mechanistically poorly understood, particularly at the spatial and fiber type-specific levels. Here, we present a spatial transcriptomic atlas of skeletal muscle from young and aged mice, resolving age-associated transcriptional reprogramming across distinct myofiber types and tissue compartments. Our analyses uncover coordinated alterations in sarcomeric organization, excitation-contraction coupling, and oxidative stress responses, together with fiber type-specific metabolic rewiring toward glycolytic or oxidative programs. We also delineate conserved molecular signatures across muscles and species, highlighting Car3 as a potential pan-muscle biomarker of sarcopenia. In this context, we identify selective downregulation of key enzymes in the polyamine biosynthetic pathway, including Amd1 and Smox, resulting in reduced spermidine levels in aged muscle. This decline in polyamine availability also impacts muscle-resident cell populations. Indeed, pharmacological inhibition of Amd1 in fibro-adipogenic progenitors (FAPs) recapitulates aging-associated phenotypes, including myofibroblast differentiation, extracellular matrix dysregulation, and impaired support for satellite cell-mediated myogenesis. Collectively, our work reveals spatially organized, fiber type-specific, and polyamine-linked mechanisms of muscle aging and highlights the polyamine pathway as a promising therapeutic target to counteract sarcopenia.
2026-07-13 | GSE308816 | GEO
Project description:This program aims at identifying a muscle gene signature associated with aging in rat sarcopenia model The profiling data was analyzed by identifying genes that were up- and down-regulated at selected p value and fold change in the muscle of aged rats compared to the young controls.
2013-03-22 | E-GEOD-38077 | biostudies-arrayexpress
Project description:Skeletal muscle allows voluntary movement and plays a key role in regulating metabolism and homeostasis in the organism. Adult muscle stem cells, MuSCs, are responsible for muscle growth and regeneration. Skeletal muscle suffers from sarcopenia (muscle mass and function loss) during the aging process. Burgeoning evidence suggests that cellular senescence drives MuSC dysfunction in muscle aging. Activation of senescence-associated secretory phenotype (SASP) factors, which is one of the hallmarks of senescence, may be a driving mechanism of sarcopenia but no study so far has clearly defined cellular senescence atlas and SASP components in aging human muscles. Here in this study we propose to profile aging and senescence atlases in aging muscles using the state-of-art multiomics approaches. Our pilot results demonstrate the prevalence of cellular senescence and the dynamics/heterogeneity of SASPs in aging human muscle. Furthermore, regulators governing senescence state and SASP induction were defined. Moreover, we demonstrated the potential of senotherapeutic targeting for sarcopenia treatment. In the project we propose (1) To complete single cell multiomics mapping of aging muscle atlas. (2) To further elucidate cellular senescence in aging muscle. (3) To investigate JUNB regulation of MuSC SASP induction in aging muscle. (4) To test the potential use of senotherapeutics on aging muscle. Once completed, findings from this study will uncover novel knowledge of how MuSC senescence is involved in niche alteration and muscle aging through SASPs and demonstrate the possibility of developing senotherapeutics for treating sarcopenia.
2025-05-09 | GSE268953 | GEO